Effect of Different Specifications of Symbicort Turbuhaler on the Treatment of Patients with Bronchial Asthma

To investigate the efficacy of different sizes symbicort turbuhaler in treatment bronchial asthma and its effect on eosinophils. 138 patients diagnosed with treated our hospital from January 2019 to 2020 were selected randomly divided into high dose (n=69) low groups both doses Symbicortol top conventional regimen, which low-dose group was 80 μg/4.5 μg/inhalation: 1 inhalation/inhalation, twice a day, for 8 w. The 160 results showed that after treatment, arterial partial pressure oxygen decreased carbon dioxide blood saturation increased compared those before more obvious changes (p<0.01). After forced expiratory volume, volume/forced vital capacity peak flow levels significantly (p<0.05), while rate percentage (p<0.05) indexes obviously eotaxin-2, C-C Motif Chemokine Receptor 3 Mucin-5ACCurated lower above total clinical efficiency 92.75 %, higher than (79.71 %) difference statistically significant. There no significant incidence between two (p>0.05). In asthma, are able control disease, promote rapid recovery improve respiratory status an ideal safety.